Newsroom
Sorted by: Latest
-
AmeriHealth Caritas Makes Strategic Investment in Deon Health
NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)--AmeriHealth Caritas announced today a strategic investment in Deon Health, a Michigan-based specialty managed care organization built specifically to serve people with intellectual and developmental disabilities (I/DD). The investment will support Deon Health's work to advance specialized, coordinated care for people with I/DD through a purpose-built care model centered on individual needs, choices, and local communities, supported by specialized technology...
-
Fifth Third Bancorp Commences Registered Exchange Offer
CINCINNATI--(BUSINESS WIRE)--Fifth Third Bancorp (NYSE: FITB) today announced the commencement of its offer to exchange (the “Registered Exchange Offer”) any and all of its outstanding unregistered senior notes (the “Restricted Notes”) previously issued pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), for an equal principal amount of new notes registered under the Securities Act (the “Registered Notes”), as set forth b...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 20.08.2026 FVD. IE00BKVKW020 250,002.00 USD 7,768,365.04 31.073 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 20.08.2026 FCSG IE00BKPSPT20 750,002.00 USD 34,390,124.70 45.853 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 20.08.2026 FXGB LN IE00BD5HBR05 47,692.00 GBP 1,011,769.53 28.921 ...
-
Sky Harbour Announces Increase to Recent Registered Direct Common Stock Placement, Updates Investor Conference Calendar, and Announces Filing of Construction Reports
WEST HARRISON, N.Y.--(BUSINESS WIRE)--Sky Harbour Group Corporation (NYSE: SKYH, SKYH WS) (“SHG” or the “Company”), an aviation infrastructure company building the first nationwide network of Home Base Operator (“HBO”) campuses for business aircraft, announced its calendar of investor conferences for the next two months, the filing of its monthly construction reports and a $10 million increase of its recent registered direct common stock placement with an additional strategic investor. Investor...
-
Rick George Joins Alliant Insurance Services’ Employee Benefits Group in Arkansas
IRVINE, Calif.--(BUSINESS WIRE)--Alliant Insurance Services has hired Rick George as First Vice President within its Employee Benefits Group. Based in Fayetteville, Arkansas, George will work with employers nationwide to develop employee benefits strategies that improve the employee experience, strengthen workplace culture, and manage long-term healthcare costs.“Rick brings a strong record of leadership in employee benefits, healthcare strategy, and technology-enabled transformation,” said Kevin...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 20.08.2026 FTFX IE00BD5HBQ97 63,402.00 USD 1,781,648.59 28.101 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 20.08.2026 FJUL.LN IE000YJBT6I5 100,002.00 USD 2,916,356.54 29.163 ...
-
Gossamer Bio Announces Up to $250 Million Structured Private Placement, Including $150 Million of Committed Capital, to Fund Seralutinib Through Potential FDA Approval
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS) (the “Company” or “Gossamer”), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced that it has entered into a securities purchase agreement with certain new and existing institutional investors for a private placement financing...